Royal Liverpool University Hospital - Research and Development Department

Liverpool University Hospitals NHS Foundation Trust

Diabetes Mellitus

Type 1 Diabetes Mellitus

Frailty

ITBMed

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The goal of this study is to determine if treatment with TCD601 improves beta-cell function in adults recently diagnosed with type 1 diabetes compared to placebo.

A Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients

Liverpool University Hospitals NHS Foundation Trust | Royal Liverpool University Hospital - Research and Development Department

Site insights

Work at this site?

Active trials

A Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients (STRIDE)

Trial sponsors